Word

ORLANCE

Status

Pending

Status Code

732

Status Date

Tuesday, December 19, 2023

Serial Number

90507936

Mark Type

4000

Filing Date

Wednesday, February 3, 2021

Published for Opposition

Tuesday, May 3, 2022

Trademark Owner History

Orlance, Inc. - Owner At Publication

Classifications

5 Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, namely, autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer

44 Medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer

10 Medical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, namely, automatic vaccination apparatus

42 Research and development of vaccines; research and development of medicines, namely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents

Trademark Events

Dec 21, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 19, 2023

Sou Extension 3 Granted

Dec 19, 2023

Sou Extension 3 Filed

Dec 19, 2023

Sou Teas Extension Received

Jun 22, 2023

Notice Of Approval Of Extension Request E-Mailed

Jun 20, 2023

Sou Extension 2 Granted

Jun 20, 2023

Sou Extension 2 Filed

Jun 20, 2023

Sou Teas Extension Received

Dec 23, 2022

Notice Of Approval Of Extension Request E-Mailed

Dec 21, 2022

Sou Extension 1 Granted

Dec 21, 2022

Sou Extension 1 Filed

Dec 21, 2022

Sou Teas Extension Received

Jun 28, 2022

Noa E-Mailed - Sou Required From Applicant

May 3, 2022

Official Gazette Publication Confirmation E-Mailed

May 3, 2022

Published For Opposition

Apr 13, 2022

Notification Of Notice Of Publication E-Mailed

Mar 27, 2022

Assigned To Lie

Mar 25, 2022

Approved For Pub - Principal Register

Mar 25, 2022

Examiner's Amendment Entered

Mar 25, 2022

Notification Of Examiners Amendment E-Mailed

Mar 25, 2022

Examiners Amendment E-Mailed

Mar 25, 2022

Examiners Amendment -Written

Feb 24, 2022

Teas/Email Correspondence Entered

Feb 23, 2022

Correspondence Received In Law Office

Feb 23, 2022

Teas Response To Office Action Received

Aug 26, 2021

Notification Of Non-Final Action E-Mailed

Aug 26, 2021

Non-Final Action E-Mailed

Aug 26, 2021

Non-Final Action Written

Aug 25, 2021

Assigned To Examiner

May 6, 2021

New Application Office Supplied Data Entered

Feb 6, 2021

New Application Entered